# Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Heparin Early for Radial Access Percutaneous Coronary Intervention)

> **NCT06890312** · NA · RECRUITING · sponsor: **University Hospital, Strasbourg, France** · enrollment: 550 (estimated)

## Conditions studied

- Coronary Angiography
- Percutaneous Coronary Intervention
- Radial Artery Occlusion
- Bleeding
- Anticoagulation

## Interventions

- **PROCEDURE:** Administration of heparin after sheath insertion
- **PROCEDURE:** Administration of heparin prior to sheath insertion

## Key facts

- **NCT ID:** NCT06890312
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-05
- **Primary completion:** 2026-01
- **Final completion:** 2026-01
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06890312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06890312, "Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Heparin Early for Radial Access Percutaneous Coronary Intervention)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06890312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*